Edition:
United Kingdom

Aldeyra Therapeutics Inc (ALDX.OQ)

ALDX.OQ on NASDAQ Stock Exchange Capital Market

5.69USD
5:18pm BST
Change (% chg)

$0.01 (+0.18%)
Prev Close
$5.68
Open
$5.70
Day's High
$5.76
Day's Low
$5.63
Volume
9,802
Avg. Vol
125,978
52-wk High
$16.70
52-wk Low
$4.99

About

Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes. The Company... (more)

Overall

Beta: 0.51
Market Cap(Mil.): $156.15
Shares Outstanding(Mil.): 27.49
Dividend: --
Yield (%): --

Financials

  ALDX.OQ Industry Sector
P/E (TTM): -- 95.67 34.23
EPS (TTM): -1.96 -- --
ROI: -79.69 7.62 12.65
ROE: -80.57 8.05 17.19

Aldeyra's eye drug meets main goal in late-stage study, shares surge

Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

26 Mar 2019

Aldeyra's eye drug meets main goal in late-stage study, shares surge

March 26 Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

26 Mar 2019

Earnings vs. Estimates